Report Detail
Global HPV Genetic Testing Market Growth (Status and Outlook) 2022-2028
- RnM4496058 |
- 30 November, 2022 |
- Global |
- 112 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for HPV Genetic Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC HPV Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States HPV Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe HPV Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China HPV Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key HPV Genetic Testing players cover BGI Group, Vcanbio Cell and Gene Engineering Corp, Oxford Nanopore Technologies, PacBio and Macrogen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global HPV Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global HPV Genetic Testing market, with both quantitative and qualitative data, to help readers understand how the HPV Genetic Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the HPV Genetic Testing market and forecasts the market size by Type (HC-Ⅱ, DNA Microarray and Real-time PCR), by Application (Genital Warts Diagnosis, Cervical Cancer Diagnosis and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
HC-Ⅱ
DNA Microarray
Real-time PCR
Segmentation by application
Genital Warts Diagnosis
Cervical Cancer Diagnosis
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
BGI Group
Vcanbio Cell and Gene Engineering Corp
Oxford Nanopore Technologies
PacBio
Macrogen
Bruker
QIAGEN
10X Genomics
Agilent Technologies
Illumina
Thermo Fisher Scientific
Testing
LifeLabs
GenPath Diagnostics
Hologic Women's Health
Mayo Clinic
Enzo Biochem
Seegene
The BioArte
Chapter Introduction
Chapter 1: Scope of HPV Genetic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global HPV Genetic Testing market size and CAGR, HPV Genetic Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: HPV Genetic Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global HPV Genetic Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global HPV Genetic Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including BGI Group, Vcanbio Cell and Gene Engineering Corp, Oxford Nanopore Technologies, PacBio, Macrogen, Bruker, QIAGEN, 10X Genomics and Agilent Technologies, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global HPV Genetic Testing Market Size 2017-2028
- 2.1.2 HPV Genetic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 HPV Genetic Testing Segment by Type
- 2.2.1 HC-Ⅱ
- 2.2.2 DNA Microarray
- 2.2.3 Real-time PCR
- 2.3 HPV Genetic Testing Market Size by Type
- 2.3.1 HPV Genetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global HPV Genetic Testing Market Size Market Share by Type (2017-2022)
- 2.4 HPV Genetic Testing Segment by Application
- 2.4.1 Genital Warts Diagnosis
- 2.4.2 Cervical Cancer Diagnosis
- 2.4.3 Other
- 2.5 HPV Genetic Testing Market Size by Application
- 2.5.1 HPV Genetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global HPV Genetic Testing Market Size Market Share by Application (2017-2022)
3 HPV Genetic Testing Market Size by Player
- 3.1 HPV Genetic Testing Market Size Market Share by Players
- 3.1.1 Global HPV Genetic Testing Revenue by Players (2020-2022)
- 3.1.2 Global HPV Genetic Testing Revenue Market Share by Players (2020-2022)
- 3.2 Global HPV Genetic Testing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 HPV Genetic Testing by Regions
- 4.1 HPV Genetic Testing Market Size by Regions (2017-2022)
- 4.2 Americas HPV Genetic Testing Market Size Growth (2017-2022)
- 4.3 APAC HPV Genetic Testing Market Size Growth (2017-2022)
- 4.4 Europe HPV Genetic Testing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa HPV Genetic Testing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas HPV Genetic Testing Market Size by Country (2017-2022)
- 5.2 Americas HPV Genetic Testing Market Size by Type (2017-2022)
- 5.3 Americas HPV Genetic Testing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC HPV Genetic Testing Market Size by Region (2017-2022)
- 6.2 APAC HPV Genetic Testing Market Size by Type (2017-2022)
- 6.3 APAC HPV Genetic Testing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe HPV Genetic Testing by Country (2017-2022)
- 7.2 Europe HPV Genetic Testing Market Size by Type (2017-2022)
- 7.3 Europe HPV Genetic Testing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa HPV Genetic Testing by Region (2017-2022)
- 8.2 Middle East & Africa HPV Genetic Testing Market Size by Type (2017-2022)
- 8.3 Middle East & Africa HPV Genetic Testing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global HPV Genetic Testing Market Forecast
- 10.1 Global HPV Genetic Testing Forecast by Regions (2023-2028)
- 10.1.1 Global HPV Genetic Testing Forecast by Regions (2023-2028)
- 10.1.2 Americas HPV Genetic Testing Forecast
- 10.1.3 APAC HPV Genetic Testing Forecast
- 10.1.4 Europe HPV Genetic Testing Forecast
- 10.1.5 Middle East & Africa HPV Genetic Testing Forecast
- 10.2 Americas HPV Genetic Testing Forecast by Country (2023-2028)
- 10.2.1 United States HPV Genetic Testing Market Forecast
- 10.2.2 Canada HPV Genetic Testing Market Forecast
- 10.2.3 Mexico HPV Genetic Testing Market Forecast
- 10.2.4 Brazil HPV Genetic Testing Market Forecast
- 10.3 APAC HPV Genetic Testing Forecast by Region (2023-2028)
- 10.3.1 China HPV Genetic Testing Market Forecast
- 10.3.2 Japan HPV Genetic Testing Market Forecast
- 10.3.3 Korea HPV Genetic Testing Market Forecast
- 10.3.4 Southeast Asia HPV Genetic Testing Market Forecast
- 10.3.5 India HPV Genetic Testing Market Forecast
- 10.3.6 Australia HPV Genetic Testing Market Forecast
- 10.4 Europe HPV Genetic Testing Forecast by Country (2023-2028)
- 10.4.1 Germany HPV Genetic Testing Market Forecast
- 10.4.2 France HPV Genetic Testing Market Forecast
- 10.4.3 UK HPV Genetic Testing Market Forecast
- 10.4.4 Italy HPV Genetic Testing Market Forecast
- 10.4.5 Russia HPV Genetic Testing Market Forecast
- 10.5 Middle East & Africa HPV Genetic Testing Forecast by Region (2023-2028)
- 10.5.1 Egypt HPV Genetic Testing Market Forecast
- 10.5.2 South Africa HPV Genetic Testing Market Forecast
- 10.5.3 Israel HPV Genetic Testing Market Forecast
- 10.5.4 Turkey HPV Genetic Testing Market Forecast
- 10.5.5 GCC Countries HPV Genetic Testing Market Forecast
- 10.6 Global HPV Genetic Testing Forecast by Type (2023-2028)
- 10.7 Global HPV Genetic Testing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 BGI Group
- 11.1.1 BGI Group Company Information
- 11.1.2 BGI Group HPV Genetic Testing Product Offered
- 11.1.3 BGI Group HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 BGI Group Main Business Overview
- 11.1.5 BGI Group Latest Developments
- 11.2 Vcanbio Cell and Gene Engineering Corp
- 11.2.1 Vcanbio Cell and Gene Engineering Corp Company Information
- 11.2.2 Vcanbio Cell and Gene Engineering Corp HPV Genetic Testing Product Offered
- 11.2.3 Vcanbio Cell and Gene Engineering Corp HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Vcanbio Cell and Gene Engineering Corp Main Business Overview
- 11.2.5 Vcanbio Cell and Gene Engineering Corp Latest Developments
- 11.3 Oxford Nanopore Technologies
- 11.3.1 Oxford Nanopore Technologies Company Information
- 11.3.2 Oxford Nanopore Technologies HPV Genetic Testing Product Offered
- 11.3.3 Oxford Nanopore Technologies HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Oxford Nanopore Technologies Main Business Overview
- 11.3.5 Oxford Nanopore Technologies Latest Developments
- 11.4 PacBio
- 11.4.1 PacBio Company Information
- 11.4.2 PacBio HPV Genetic Testing Product Offered
- 11.4.3 PacBio HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 PacBio Main Business Overview
- 11.4.5 PacBio Latest Developments
- 11.5 Macrogen
- 11.5.1 Macrogen Company Information
- 11.5.2 Macrogen HPV Genetic Testing Product Offered
- 11.5.3 Macrogen HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Macrogen Main Business Overview
- 11.5.5 Macrogen Latest Developments
- 11.6 Bruker
- 11.6.1 Bruker Company Information
- 11.6.2 Bruker HPV Genetic Testing Product Offered
- 11.6.3 Bruker HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bruker Main Business Overview
- 11.6.5 Bruker Latest Developments
- 11.7 QIAGEN
- 11.7.1 QIAGEN Company Information
- 11.7.2 QIAGEN HPV Genetic Testing Product Offered
- 11.7.3 QIAGEN HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 QIAGEN Main Business Overview
- 11.7.5 QIAGEN Latest Developments
- 11.8 10X Genomics
- 11.8.1 10X Genomics Company Information
- 11.8.2 10X Genomics HPV Genetic Testing Product Offered
- 11.8.3 10X Genomics HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 10X Genomics Main Business Overview
- 11.8.5 10X Genomics Latest Developments
- 11.9 Agilent Technologies
- 11.9.1 Agilent Technologies Company Information
- 11.9.2 Agilent Technologies HPV Genetic Testing Product Offered
- 11.9.3 Agilent Technologies HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Agilent Technologies Main Business Overview
- 11.9.5 Agilent Technologies Latest Developments
- 11.10 Illumina
- 11.10.1 Illumina Company Information
- 11.10.2 Illumina HPV Genetic Testing Product Offered
- 11.10.3 Illumina HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Illumina Main Business Overview
- 11.10.5 Illumina Latest Developments
- 11.11 Thermo Fisher Scientific
- 11.11.1 Thermo Fisher Scientific Company Information
- 11.11.2 Thermo Fisher Scientific HPV Genetic Testing Product Offered
- 11.11.3 Thermo Fisher Scientific HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Thermo Fisher Scientific Main Business Overview
- 11.11.5 Thermo Fisher Scientific Latest Developments
- 11.12 Testing
- 11.12.1 Testing Company Information
- 11.12.2 Testing HPV Genetic Testing Product Offered
- 11.12.3 Testing HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Testing Main Business Overview
- 11.12.5 Testing Latest Developments
- 11.13 LifeLabs
- 11.13.1 LifeLabs Company Information
- 11.13.2 LifeLabs HPV Genetic Testing Product Offered
- 11.13.3 LifeLabs HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 LifeLabs Main Business Overview
- 11.13.5 LifeLabs Latest Developments
- 11.14 GenPath Diagnostics
- 11.14.1 GenPath Diagnostics Company Information
- 11.14.2 GenPath Diagnostics HPV Genetic Testing Product Offered
- 11.14.3 GenPath Diagnostics HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 GenPath Diagnostics Main Business Overview
- 11.14.5 GenPath Diagnostics Latest Developments
- 11.15 Hologic Women's Health
- 11.15.1 Hologic Women's Health Company Information
- 11.15.2 Hologic Women's Health HPV Genetic Testing Product Offered
- 11.15.3 Hologic Women's Health HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Hologic Women's Health Main Business Overview
- 11.15.5 Hologic Women's Health Latest Developments
- 11.16 Mayo Clinic
- 11.16.1 Mayo Clinic Company Information
- 11.16.2 Mayo Clinic HPV Genetic Testing Product Offered
- 11.16.3 Mayo Clinic HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Mayo Clinic Main Business Overview
- 11.16.5 Mayo Clinic Latest Developments
- 11.17 Enzo Biochem
- 11.17.1 Enzo Biochem Company Information
- 11.17.2 Enzo Biochem HPV Genetic Testing Product Offered
- 11.17.3 Enzo Biochem HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Enzo Biochem Main Business Overview
- 11.17.5 Enzo Biochem Latest Developments
- 11.18 Seegene
- 11.18.1 Seegene Company Information
- 11.18.2 Seegene HPV Genetic Testing Product Offered
- 11.18.3 Seegene HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Seegene Main Business Overview
- 11.18.5 Seegene Latest Developments
- 11.19 The BioArte
- 11.19.1 The BioArte Company Information
- 11.19.2 The BioArte HPV Genetic Testing Product Offered
- 11.19.3 The BioArte HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 The BioArte Main Business Overview
- 11.19.5 The BioArte Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on HPV Genetic Testing. Industry analysis & Market Report on HPV Genetic Testing is a syndicated market report, published as Global HPV Genetic Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of HPV Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
